RAPT Therapeutics $100 million at-the-market offering
Davis Polk advised the sales agents on the SEC-registered at-the-market offering by RAPT Therapeutics, Inc. of its common stock for up to an aggregate amount of $100 million.
RAPT…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Revance Therapeutics $125 million at-the-market offering
Davis Polk advised the sales agent on the SEC-registered at-the-market offering by Revance Therapeutics, Inc. of its common stock for up to an aggregate amount of $125 million.
Based…
Favorable decision in Comcast antitrust litigation
We represent Comcast in antitrust litigation brought by Altitude Sports & Entertainment, a Denver regional sports network (RSN) with rights to the NBA’s Denver Nuggets and NHL’s…
Frontier Communications DIP-to-exit financing, including $2.55 billion in notes
Davis Polk advised the representatives of the several initial purchasers in connection with the Rule 144A/Regulation S offering by Frontier Communications Corporation of $1.55 billion…
Bertelsmann $2.175 billion acquisition of Simon & Schuster
Davis Polk is advising Bertelsmann on the $2.175 billion acquisition by its global trade book publishing group, Penguin Random House, of Simon & Schuster from ViacomCBS. The transaction…
Continental Resources $1.5 billion notes offering and concurrent tender offers
Davis Polk advised the representative of the initial purchasers on a Rule 144A/Regulation S offering by Continental Resources, Inc. of $1.5 billion aggregate principal amount of its 5…
Sizzling Platter $350 million high-yield notes and $65 million credit facility
Davis Polk advised the initial purchasers in connection with a Rule 144A/Regulation S offering by Sizzling Platter, LLC and Sizzling Platter Issuer Corporation of $350 million…
Esperion Therapeutics $250 million convertible senior subordinated notes
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Esperion Therapeutics, Inc. of $250 million aggregate principal amount of…
FTS International emergence from bankruptcy
Davis Polk advised an ad hoc group of senior secured noteholders in connection with the chapter 11 restructuring of FTS International, Inc. and certain of its subsidiaries (collectively, …
GoPro $143.75 million convertible senior notes offering
Davis Polk advised the representative of the initial purchasers in a Rule 144A offering by GoPro, Inc. of $143.75 million aggregate principal amount of 1.250% convertible senior notes due…